Publication | Closed Access
A prospective observational study of the incidence, natural history, and risk factors for intravenous immunoglobulin‐mediated hemolysis
25
Citations
12
References
2021
Year
IVIG-mediated hemolysis is common and frequently severe. Monitoring for 5-10 days following an infusion should be considered in non-O patients receiving high-dose IVIG with known risk factors.
| Year | Citations | |
|---|---|---|
Page 1
Page 1